This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Naor Bar-Zeev, Deputy Director of the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health. He examines the scientific guidelines governing COVID-19 vaccine phase 3 clinical trials, including a broad demographic representation to ensure vaccine safety across multiple populations, and the need to address vaccine hesitancy as well as the global supply chain needed to distribute billions of doses.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Spotify | Android | Podchaser | TuneIn | RSS | More
Originally broadcast December 26, 2024 Dr. Amit Sood is called the “Happiness Doctor” for a…
Originally broadcast December 20, 2024 Billionaires who dream of extending human life, including Elon Musk,…
Originally broadcast December 12, 2024 Nurse practitioners, at 385,000 strong in the U.S., are increasingly…
Originally broadcast December 5, 2024 HIV/AIDS experts are cautiously watching as President Trump and his…
Originally broadcast on November 27, 2024 Dr. Amit Sood is called the “Happiness Doctor” for…
Originally broadcast November 21, 2024 TV ads focused on health care issues — including transgender…